Spascupreel

Product NDC

50114-7040

Requested package NDC

50114-7040-1

11-digit product format

501147040

Labeler code

50114

Product ID

50114-7040_72a712a7-7d1f-436c-8f18-ddbc97047ce4

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

ACONITUM NAPELLUS, AMMONIUM BROMIDE, CITRULLUS COLOCYNTHIS FRUIT PULP, ATROPINE SULFATE, GELSEMIUM SEMPERVIRENS ROOT, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, VERATRUM ALBUM ROOT, PASSIFLORA INCARNATA FLOWERING TOP, MATRICARIA RECUTITA, AMANITA MUSCARIA FRUITING BODY and CUPRIC SULFATE

Dosage form

INJECTION

Route

INTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS

Labeler

MediNatura Inc

Marketing category

UNAPPROVED HOMEOPATHIC

Marketing start

2014-08-30

Marketing end

2023-11-30

Substance

ACONITUM NAPELLUS; AMMONIUM BROMIDE; CITRULLUS COLOCYNTHIS FRUIT PULP; ATROPINE SULFATE; GELSEMIUM SEMPERVIRENS ROOT; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; VERATRUM ALBUM ROOT; PASSIFLORA INCARNATA FLOWERING TOP; MATRICARIA RECUTITA; AMANITA MUSCARIA FRUITING BODY; CUPRIC SULFATE

Active strength

6 [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL; [hp_X]/1.1mL

Pharmacologic classes

Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]

NDC exclude flag

No

Listing certified through

0000-00-00

Current FDA listing

Historical FDA.report record